Skip to main content
DeutschDE
European Commission logo print header

Active controlled transdermal drug delivery systems

Ziel

The proposal aims to develop functional materials and systems to fulfill the need for safe, actively controlled transdermal drug delivery. The effective combination of the partner's skills and resources will develop drug delivery systems to meet several patient centred objectives: e.g.wider use of self administered drugs , at home with a wearable system, more accurate matching of drug dose to drug need, avoiding side effects and long-term complications in chronic diseases (e.g. diabetes and osteoporosis) and improve patient compliance by replacing self injection. This project seeks to extend the scale and range of drugs currently administered non-invasively-e.g. beyond small scale anesthetics and pain killers. The economic impact is to reduce hospitalization, reduce use of PVC consumables and develop a new sector of European health industry .

Wissenschaftliches Gebiet

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CSC - Cost-sharing contracts

Koordinator

BAXTER RESEARCH AND DEVELOPMENT EUROPE
EU-Beitrag
Keine Daten
Adresse
Rue du Progres 7
1400 NIVELLES
Belgien

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (5)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 12 April 2005

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/G5RD-CT-1999-00077/de

European Union, 2024